Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 2:48 pm Purchase |
2023-02-08 | 13G | ARCA biopharma, Inc. ABIO |
BML Investment Partners, L.P. | 71,521 5.950% |
8,033 (+12.65%) |
Filing History |
| 2022-07-08 4:30 pm Purchase |
2022-07-01 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Funds, LP | 215,093 17.910% |
215,093 (New Position) |
Filing History |
| 2022-06-21 4:30 pm Purchase |
2022-06-15 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 215,093 17.910% |
15,320 (+7.67%) |
Filing History |
| 2022-05-27 4:40 pm Purchase |
2022-05-25 | 13D | ARCA biopharma, Inc. ABIO |
Ma-Weaver Jacob | 215,038 17.910% |
215,038 (New Position) |
Filing History |
| 2022-05-11 4:56 pm Purchase |
2022-05-09 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 199,773 16.640% |
18,848 (+10.42%) |
Filing History |
| 2022-04-14 4:38 pm Purchase |
2022-04-12 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 180,925 15.060% |
18,842 (+11.63%) |
Filing History |
| 2022-04-04 5:10 pm Purchase |
2022-03-31 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 162,083 13.500% |
84,163 (+108.01%) |
Filing History |
| 2022-03-28 4:20 pm Purchase |
2022-03-18 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 77,920 6.490% |
77,920 (New Position) |
Filing History |
| 2022-01-27 3:53 pm Purchase |
2022-01-24 | 13G | ARCA biopharma, Inc. ABIO |
BML Investment Partners, L.P. | 63,488 5.300% |
63,488 (New Position) |
Filing History |
| 2021-02-10 1:45 pm Purchase |
2020-12-31 | 13G | ARCA biopharma, Inc. ABIO |
Renaissance Technologies LLC | 17,125 2.200% |
5,244 (+44.14%) |
Filing History |
| 2021-02-10 10:30 am Sale |
2020-12-31 | 13G | ARCA biopharma, Inc. ABIO |
Altium Capital Management LLC | 0 0.000% |
-14,500 (Position Closed) |
Filing History |
| 2021-01-06 12:31 pm Sale |
2020-12-31 | 13G | ARCA biopharma, Inc. ABIO |
SABBY MANAGEMENT LLC | 0 0.000% |
-16,168 (Position Closed) |
Filing History |
| 2020-06-10 3:06 pm Purchase |
2020-06-01 | 13G | ARCA biopharma, Inc. ABIO |
Altium Capital Management LLC | 14,500 9.990% |
14,500 (New Position) |
Filing History |
| 2020-06-01 2:07 pm Purchase |
2020-06-01 | 13G | ARCA biopharma, Inc. ABIO |
SABBY MANAGEMENT LLC | 16,168 11.000% |
16,168 (New Position) |
Filing History |